Madam Chair, this gives me the opportunity to clarify what the guideline is about.
The guideline is not, as I said in my opening statement, about diagnosis but about screening. It's for people who have no symptoms. That's the first thing.
The second thing is that it's not about screening women at high risk. If you read the guideline, you'll see that we incorporated women at average risk and women at moderately increased risk. We define “moderately increased risk” as a woman having one first degree or two second degree relatives diagnosed after age 50.
Anything that's more than that or different from this is not considered “moderately increased”, but probably goes into the high-risk strata, for which we don't have a recommendation because that was not our mandate.